摘要
鼻咽癌的诱导化疗和同期放化疗一直是临床研究的热点。以顺铂为代表的铂类药物在提高鼻咽癌治疗疗效的同时也带来了很大的不良反应，新型铂类奈达铂的出现在保证疗效的同时降低了化疗的不良反应。
Inductive chemotherapy and concurrent chemoradiotherapy have been a focus on the clinical research in the treatment of nasopharyngeal carcinoma. Cisplatin, as a kind of representative platinum drug, can improve the curative effect, but it also brings a lot of side effects to nasopharyngeal carcinoma patients. The new kind of platinum drug-nedaplatin, can not only guarantee the curative effect but also reduce the side effects of chemotherapy.
出处
《国际肿瘤学杂志》
CAS
2012年第9期680-682,共3页
Journal of International Oncology
基金
广西卫生医疗重点科研课题（重2011074）
关键词
鼻咽肿瘤
奈达铂
诱导化疗
同期放化疗
Nasopharyngeal neoplasms
Nedaplatin
Inductive chemotherapy
Concomitant chemo- radiotherapy
